Structural basis for activation of the complement system by component C4 cleavage

被引:91
|
作者
Kidmose, Rune T. [1 ]
Laursen, Nick S. [1 ]
Dobo, Jozsef [3 ]
Kjaer, Troels R. [2 ]
Sirotkina, Sofia [1 ]
Yatime, Laure [1 ]
Sottrup-Jensen, Lars [1 ]
Thiel, Steffen [2 ]
Gal, Peter [3 ]
Andersen, Gregers R. [1 ]
机构
[1] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark
[2] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark
[3] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
crystallography; pattern recognition; proteolysis; structural biology; MANNAN-BINDING LECTIN; CONTROL PROTEIN MODULES; RECOGNITION; REVEALS; DOMAIN; MASP-2; IDENTIFICATION; INHIBITORS; THIOESTER; ENZYME;
D O I
10.1073/pnas.1208031109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An essential aspect of innate immunity is recognition of molecular patterns on the surface of pathogens or altered self through the lectin and classical pathways, two of the three well-established activation pathways of the complement system. This recognition causes activation of the MASP-2 or the C1s serine proteases followed by cleavage of the protein C4. Here we present the crystal structures of the 203-kDa human C4 and the 245-kDa C4.MASP-2 substrate.enzyme complex. When C4 binds to MASP-2, substantial conformational changes in C4 are induced, and its scissile bond region becomes ordered and inserted into the protease catalytic site in a manner canonical to serine proteases. In MASP-2, an exosite located within the CCP domains recognizes the C4 C345C domain 60 angstrom from the scissile bond. Mutations in C4 and MASP-2 residues at the C345C-CCP interface inhibit the intermolecular interaction and C4 cleavage. The possible assembly of the huge in vivo enzyme-substrate complex consisting of glycan-bound mannan-binding lectin, MASP-2, and C4 is discussed. Our own and prior functional data suggest that C1s in the classical pathway of complement activated by, e. g., antigen-antibody complexes, also recognizes the C4 C345C domain through a CCP exosite. Our results provide a unified structural framework for understanding the early and essential step of C4 cleavage in the elimination of pathogens and altered self through two major pathways of complement activation.
引用
收藏
页码:15425 / 15430
页数:6
相关论文
共 50 条
  • [21] REVISED NOMENCLATURE FOR HUMAN-COMPLEMENT COMPONENT C4
    KAZATCHKINE, M
    MAUFF, G
    ABBAL, M
    ALPER, GA
    CHRISTIANSEN, F
    CUCCIA, M
    DAWKINS, R
    DOXIADIS, G
    DUTOIT, E
    GILES, C
    GESERICK, G
    HAUPTMANN, G
    HOBART, M
    LOKKI, M
    MCLEAN, R
    NAKAMURA, S
    ONEILL, G
    PARTANEN, J
    RITTNER, C
    SCHNEIDER, PM
    SEGURADO, O
    SIEMENS, I
    SUZUKI, K
    DEMESSIAS, IT
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1992, 70 (04) : 531 - 535
  • [22] REVISED NOMENCLATURE FOR HUMAN-COMPLEMENT COMPONENT C4
    KAZATCHKINE, M
    MAUFF, G
    ABBAL, M
    ALPER, CA
    CHRISTIANSEN, F
    CUCCIA, M
    DAWKINS, R
    DOXIADIS, G
    DUTOIT, F
    GILES, C
    GESERICK, G
    HAUPTMANN, G
    HOBART, M
    LOKKI, M
    MCLEAN, R
    NAKAMURA, S
    ONEILL, G
    PARTANEN, J
    RITTNER, C
    SCHNEIDER, PM
    SEGURADO, O
    SIEMENS, I
    SUZUKI, K
    DEMESSIAS, IT
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 1993, 20 (04): : 301 - 305
  • [23] Complement factor C4 activation in patients with hereditary angioedema
    Aabom, Anne
    Bygum, Anette
    Koch, Claus
    CLINICAL BIOCHEMISTRY, 2017, 50 (15) : 816 - 821
  • [24] INVIVO ACTIVATION OF THE 4TH COMPONENT OF THE COMPLEMENT-SYSTEM (C4) IN PREMATURE AND TERM INFANTS WITH GENERALIZED BACTERIAL-INFECTION
    NURNBERGER, W
    STANNIGEL, H
    MUNTEL, V
    MICHELMANN, I
    WAHN, V
    GOBEL, U
    KLINISCHE PADIATRIE, 1990, 202 (03): : 141 - 146
  • [25] Complement activation and C4 deficiency in patients with lupus nephritis
    Dippel, E
    Waldherr, R
    Andrassy, K
    Kirschfink, M
    MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 304 - 304
  • [26] ISOLATION AND STRUCTURE OF C4, 4TH COMPONENT OF HUMAN COMPLEMENT
    GIGLI, I
    VONZABERN, I
    PORTER, RR
    BIOCHEMICAL JOURNAL, 1977, 165 (03) : 439 - &
  • [27] Shedding light on the role of complement C4 activation in cancer
    Cheung, Darin
    Hassan, Mohammad Ali
    Huynh, Tri
    Feng, Xiaodong
    Wang, Hongbin
    HUMAN IMMUNOLOGY, 2025, 86 (01)
  • [28] DEFICIENCY OF THE 4TH COMPONENT OF COMPLEMENT (C4) - A FAMILY CASE
    ITOH, A
    TAKADA, A
    TOKUNAGA, K
    FUJITA, J
    YAMAMOTO, M
    SAITO, S
    YAMAGUCHI, E
    KAWAKAMI, Y
    WAKISAKA, A
    INTERNAL MEDICINE, 1994, 33 (08) : 508 - 511
  • [29] GENETICALLY CONTROLLED POLYMORPHISM OF FOURTH COMPONENT OF HUMAN COMPLEMENT (C4)
    ROSENFELD, SI
    RUDDY, S
    AUSTEN, KF
    ARTHRITIS AND RHEUMATISM, 1969, 12 (03): : 327 - +
  • [30] Genetics of human complement component C4 and evolution the central MHC
    Martinez, OP
    Longman-Jacobsen, N
    Davies, R
    Chung, EK
    Yang, Y
    Gaudieri, S
    Dawkins, RL
    Yu, CY
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : D904 - D913